Remix Therapeutics
About:
Remix Therapeutics is a biotechnology company that is working on developing small molecule medicines.
Website: https://www.remixtx.com
Twitter/X: remixthera
Top Investors: Alexandria Venture Investments, ARCH Venture Partners, Foresite Capital, Casdin Capital, Atlas Venture
Description:
Remix Therapeutics is a biotechnology business that is working on developing small-molecule medicines to reprogram ribonucleic acid processing and cure disease in novel ways. The company's medicines aid in the identification of patterns in ribonucleic acid processing and their application to control gene expression in order to change the way genes are read from the genome, correcting, enhancing, or eliminating the gene message, allowing healthcare practitioners to address disease causes at their source.
$211M
$1M to $10M
Cambridge, Massachusetts, United States
2019-01-01
Kevin Bitterman, Peter Smith
51-100
2024-01-03
Private
© 2025 bioDAO.ai